David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses the treatment trends for prostate cancer in 2017 and gives an overview of an AACR session, which focused on the “Hallmarks of Cancer” and the epigenetic phenomenon that is occurring in cancer research. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
"Hallmarks of Cancer": Treatment Trends for 2017
